Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 387 entries
Sorted by: Best Match Show Resources per page
[In Process Citation].

Orvosi hetilap

Horváth G, Gerlei Z, Gervain J, Lengyel G, Makara M, Pár A, Rókusz L, Szalay F, Tornai I, Werling K, Hunyady B.
PMID: 26667112
Orv Hetil. 2015 Dec 15;156:25-36. doi: 10.1556/OH.2015.30331.

Diagnosis and treatment of HBV/HDV infection means for the patient to be able to maintain working capacity, to increase quality of life, to prevent cancer, and to prolong life expectancy, while society benefits from eliminating the chances of further...

Cite
Horváth G, Gerlei Z, Gervain J, et al. A hepatitis B- és D-vírus-fertőzés diagnosztikája, antivirális kezelése. Magyar konszenzusajánlás. Érvényes: 2015. szeptember 12-től. [In Process Citation]. Orv Hetil. 2015;156:25-36doi: 10.1556/OH.2015.30331.
Horváth, G., Gerlei, Z., Gervain, J., Lengyel, G., Makara, M., Pár, A., Rókusz, L., Szalay, F., Tornai, I., Werling, K., & Hunyady, B. (2015). A hepatitis B- és D-vírus-fertőzés diagnosztikája, antivirális kezelése. Magyar konszenzusajánlás. Érvényes: 2015. szeptember 12-től. [In Process Citation]. Orvosi hetilap, 15625-36. https://doi.org/10.1556/OH.2015.30331
Horváth, Gábor, et al. "A hepatitis B- és D-vírus-fertőzés diagnosztikája, antivirális kezelése. Magyar konszenzusajánlás. Érvényes: 2015. szeptember 12-től." [In Process Citation]. Orvosi hetilap vol. 156 (2015): 25-36. doi: https://doi.org/10.1556/OH.2015.30331
Horváth G, Gerlei Z, Gervain J, Lengyel G, Makara M, Pár A, Rókusz L, Szalay F, Tornai I, Werling K, Hunyady B. A hepatitis B- és D-vírus-fertőzés diagnosztikája, antivirális kezelése. Magyar konszenzusajánlás. Érvényes: 2015. szeptember 12-től. [In Process Citation]. Orv Hetil. 2015 Dec 15;156:25-36. doi: 10.1556/OH.2015.30331. Hungarian. PMID: 26667112.
Copy Download .nbib Format: NLM
Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.

Current oncology (Toronto, Ont.)

Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J.
PMID: 28050152
Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21.

In recent years, risk stratification has sparked interest as an innovative approach to disease screening and prevention. The approach effectively personalizes individual risk, opening the way to screening and prevention interventions that are adapted to subpopulations. The international perspective...

Cite
Gagnon J, Lévesque E, et al. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016;23(6):e615-e625doi: 10.3747/co.23.2961.
Gagnon, J., Lévesque, E., Borduas, F., Chiquette, J., Diorio, C., Duchesne, N., Dumais, M., Eloy, L., Foulkes, W., Gervais, N., Lalonde, L., L'Espérance, B., Meterissian, S., Provencher, L., Richard, J., Savard, C., Trop, I., Wong, N., Knoppers, B. M., & Simard, J. (2016). Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Current oncology (Toronto, Ont.), 23(6), e615-e625. https://doi.org/10.3747/co.23.2961
Gagnon, J, et al. "Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies." Current oncology (Toronto, Ont.) vol. 23,6 (2016): e615-e625. doi: https://doi.org/10.3747/co.23.2961
Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21. PMID: 28050152; PMCID: PMC5176389.
Copy Download .nbib Format: NLM
Maximum-likelihood based synthesis of volumetric textures from a 2D sample.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society

Urs RD, Da Costa JP, Germain C.
PMID: 24808349
IEEE Trans Image Process. 2014 Apr;23(4):1820-30. doi: 10.1109/TIP.2014.2307477.

We propose a genuine 3D texture synthesis algorithm based on a probabilistic 2D Markov random field conceptualization, capable of capturing the visual characteristics of a texture into a unique statistical texture model. We intend to reproduce, in the volumetric...

Cite
Urs RD, Da Costa JP, Germain C. Maximum-likelihood based synthesis of volumetric textures from a 2D sample. IEEE Trans Image Process. 2014;23(4):1820-30doi: 10.1109/TIP.2014.2307477.
Urs, R. D., Da Costa, J. P., & Germain, C. (2014). Maximum-likelihood based synthesis of volumetric textures from a 2D sample. IEEE transactions on image processing : a publication of the IEEE Signal Processing Society, 23(4), 1820-30. https://doi.org/10.1109/TIP.2014.2307477
Urs, Radu-Dragos, et al. "Maximum-likelihood based synthesis of volumetric textures from a 2D sample." IEEE transactions on image processing : a publication of the IEEE Signal Processing Society vol. 23,4 (2014): 1820-30. doi: https://doi.org/10.1109/TIP.2014.2307477
Urs RD, Da Costa JP, Germain C. Maximum-likelihood based synthesis of volumetric textures from a 2D sample. IEEE Trans Image Process. 2014 Apr;23(4):1820-30. doi: 10.1109/TIP.2014.2307477. PMID: 24808349.
Copy Download .nbib Format: NLM
Use of fibrinolytics in abdominal and pleural collections.

Seminars in interventional radiology

Shenoy-Bhangle AS, Gervais DA.
PMID: 24293799
Semin Intervent Radiol. 2012 Dec;29(4):264-9. doi: 10.1055/s-0032-1330060.

Fluid collections that are incompletely drained despite adequate catheter position, size, and number represent a minority of abscesses but a source of great frustration for patients, surgeons, and interventional radiologists. Drainage of such complex collections is known to be...

Cite
Shenoy-Bhangle AS, Gervais DA. Use of fibrinolytics in abdominal and pleural collections. Semin Intervent Radiol. 2012;29(4):264-9doi: 10.1055/s-0032-1330060.
Shenoy-Bhangle, A. S., & Gervais, D. A. (2012). Use of fibrinolytics in abdominal and pleural collections. Seminars in interventional radiology, 29(4), 264-9. https://doi.org/10.1055/s-0032-1330060
Shenoy-Bhangle, Anuradha S, and Gervais, Debra A. "Use of fibrinolytics in abdominal and pleural collections." Seminars in interventional radiology vol. 29,4 (2012): 264-9. doi: https://doi.org/10.1055/s-0032-1330060
Shenoy-Bhangle AS, Gervais DA. Use of fibrinolytics in abdominal and pleural collections. Semin Intervent Radiol. 2012 Dec;29(4):264-9. doi: 10.1055/s-0032-1330060. PMID: 24293799; PMCID: PMC3577625.
Copy Download .nbib Format: NLM
Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Cognet M, Druais S, Gervais F, Gauthier A, Abrams KR.
PMID: 27201785
Value Health. 2014 Nov;17(7):A549. doi: 10.1016/j.jval.2014.08.1787. Epub 2014 Oct 26.

No abstract available.

Cite
Cognet M, Druais S, Gervais F, et al. Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK). Value Health. 2014;17(7):A549doi: 10.1016/j.jval.2014.08.1787.
Cognet, M., Druais, S., Gervais, F., Gauthier, A., & Abrams, K. R. (2014). Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A549. https://doi.org/10.1016/j.jval.2014.08.1787
Cognet, M, et al. "Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A549. doi: https://doi.org/10.1016/j.jval.2014.08.1787
Cognet M, Druais S, Gervais F, Gauthier A, Abrams KR. Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK). Value Health. 2014 Nov;17(7):A549. doi: 10.1016/j.jval.2014.08.1787. Epub 2014 Oct 26. PMID: 27201785.
Copy Download .nbib Format: NLM
Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Gervais F, Jiang Y, Largeron N, Nikoglou T.
PMID: 27202273
Value Health. 2014 Nov;17(7):A637. doi: 10.1016/j.jval.2014.08.2288. Epub 2014 Oct 26.

No abstract available.

Cite
Gervais F, Jiang Y, Largeron N, et al. Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection. Value Health. 2014;17(7):A637doi: 10.1016/j.jval.2014.08.2288.
Gervais, F., Jiang, Y., Largeron, N., & Nikoglou, T. (2014). Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A637. https://doi.org/10.1016/j.jval.2014.08.2288
Gervais, F, et al. "Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A637. doi: https://doi.org/10.1016/j.jval.2014.08.2288
Gervais F, Jiang Y, Largeron N, Nikoglou T. Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection. Value Health. 2014 Nov;17(7):A637. doi: 10.1016/j.jval.2014.08.2288. Epub 2014 Oct 26. PMID: 27202273.
Copy Download .nbib Format: NLM
Quantum Hall effect in hydrogenated graphene.

Physical review letters

Guillemette J, Sabri SS, Wu B, Bennaceur K, Gaskell PE, Savard M, Lévesque PL, Mahvash F, Guermoune A, Siaj M, Martel R, Szkopek T, Gervais G.
PMID: 23679754
Phys Rev Lett. 2013 Apr 26;110(17):176801. doi: 10.1103/PhysRevLett.110.176801. Epub 2013 Apr 22.

The quantum Hall effect is observed in a two-dimensional electron gas formed in millimeter-scale hydrogenated graphene, with a mobility less than 10  cm2/V·s and corresponding Ioffe-Regel disorder parameter (k(F)λ)(-1) ≫ 1. In a zero magnetic field and low temperatures,...

Cite
Guillemette J, Sabri SS, Wu B, et al. Quantum Hall effect in hydrogenated graphene. Phys Rev Lett. 2013;110(17):176801doi: 10.1103/PhysRevLett.110.176801.
Guillemette, J., Sabri, S. S., Wu, B., Bennaceur, K., Gaskell, P. E., Savard, M., Lévesque, P. L., Mahvash, F., Guermoune, A., Siaj, M., Martel, R., Szkopek, T., & Gervais, G. (2013). Quantum Hall effect in hydrogenated graphene. Physical review letters, 110(17), 176801. https://doi.org/10.1103/PhysRevLett.110.176801
Guillemette, J, et al. "Quantum Hall effect in hydrogenated graphene." Physical review letters vol. 110,17 (2013): 176801. doi: https://doi.org/10.1103/PhysRevLett.110.176801
Guillemette J, Sabri SS, Wu B, Bennaceur K, Gaskell PE, Savard M, Lévesque PL, Mahvash F, Guermoune A, Siaj M, Martel R, Szkopek T, Gervais G. Quantum Hall effect in hydrogenated graphene. Phys Rev Lett. 2013 Apr 26;110(17):176801. doi: 10.1103/PhysRevLett.110.176801. Epub 2013 Apr 22. PMID: 23679754.
Copy Download .nbib Format: NLM
Connecting defects and amorphization in UiO-66 and MIL-140 metal–organic frameworks: a combined experimental and computational study.

Physical chemistry chemical physics : PCCP

Bennett TD, Todorova TK, Baxter EF, Reid DG, Gervais C, Bueken B, Van de Voorde B, De Vos D, Keen DA, Mellot-Draznieks C.
PMID: 27144237
Phys Chem Chem Phys. 2016 Jan 21;18(3):2192-201. doi: 10.1039/c5cp06798g.

The mechanism and products of the structural collapse of the metal–organic frameworks (MOFs) UiO-66, MIL-140B and MIL-140C upon ball-milling are investigated through solid state 13C NMR and pair distribution function (PDF) studies, finding amorphization to proceed by the breaking...

Cite
Bennett TD, Todorova TK, Baxter EF, et al. Connecting defects and amorphization in UiO-66 and MIL-140 metal–organic frameworks: a combined experimental and computational study. Phys Chem Chem Phys. 2016;18(3):2192-201doi: 10.1039/c5cp06798g.
Bennett, T. D., Todorova, T. K., Baxter, E. F., Reid, D. G., Gervais, C., Bueken, B., Van de Voorde, B., De Vos, D., Keen, D. A., & Mellot-Draznieks, C. (2016). Connecting defects and amorphization in UiO-66 and MIL-140 metal–organic frameworks: a combined experimental and computational study. Physical chemistry chemical physics : PCCP, 18(3), 2192-201. https://doi.org/10.1039/c5cp06798g
Bennett, Thomas D, et al. "Connecting defects and amorphization in UiO-66 and MIL-140 metal–organic frameworks: a combined experimental and computational study." Physical chemistry chemical physics : PCCP vol. 18,3 (2016): 2192-201. doi: https://doi.org/10.1039/c5cp06798g
Bennett TD, Todorova TK, Baxter EF, Reid DG, Gervais C, Bueken B, Van de Voorde B, De Vos D, Keen DA, Mellot-Draznieks C. Connecting defects and amorphization in UiO-66 and MIL-140 metal–organic frameworks: a combined experimental and computational study. Phys Chem Chem Phys. 2016 Jan 21;18(3):2192-201. doi: 10.1039/c5cp06798g. PMID: 27144237.
Copy Download .nbib Format: NLM
Modification of the superfluid 3He phase diagram by impurity scattering.

Physical review letters

Gervais G, Haard TM, Nomura R, Mulders N, Halperin WP.
PMID: 11461570
Phys Rev Lett. 2001 Jul 16;87(3):035701. doi: 10.1103/PhysRevLett.87.035701. Epub 2001 Jun 28.

The effect of impurity scattering on the phase diagram of pure superfluid 3He has been investigated by acoustic techniques near the bulk polycritical pressure. Impurities were introduced with a 98% porous silica aerogel. In zero applied field, the equilibrium...

Cite
Gervais G, Haard TM, Nomura R, et al. Modification of the superfluid 3He phase diagram by impurity scattering. Phys Rev Lett. 2001;87(3):035701doi: 10.1103/PhysRevLett.87.035701.
Gervais, G., Haard, T. M., Nomura, R., Mulders, N., & Halperin, W. P. (2001). Modification of the superfluid 3He phase diagram by impurity scattering. Physical review letters, 87(3), 035701. https://doi.org/10.1103/PhysRevLett.87.035701
Gervais, G, et al. "Modification of the superfluid 3He phase diagram by impurity scattering." Physical review letters vol. 87,3 (2001): 035701. doi: https://doi.org/10.1103/PhysRevLett.87.035701
Gervais G, Haard TM, Nomura R, Mulders N, Halperin WP. Modification of the superfluid 3He phase diagram by impurity scattering. Phys Rev Lett. 2001 Jul 16;87(3):035701. doi: 10.1103/PhysRevLett.87.035701. Epub 2001 Jun 28. PMID: 11461570.
Copy Download .nbib Format: NLM
[THE MEDICAL EXPERTISE REPORT].

Annales de medecine legale, criminologie, police scientifique et toxicologie

GERVAIS P, DEHOUVE A.
PMID: 14334555
Ann Med Leg Criminol Police Sci Toxicol. 1965 Mar-Apr;45:191-203.

No abstract available.

Cite
GERVAIS P, DEHOUVE A. E RAPPORT D'EXPERTISE M'EDICALE. [THE MEDICAL EXPERTISE REPORT]. Ann Med Leg Criminol Police Sci Toxicol. 1965;45:191-203
GERVAIS, P., & DEHOUVE, A. (1965). E RAPPORT D'EXPERTISE M'EDICALE. [THE MEDICAL EXPERTISE REPORT]. Annales de medecine legale, criminologie, police scientifique et toxicologie, 45191-203.
GERVAIS, P, and DEHOUVE, A. "E RAPPORT D'EXPERTISE M'EDICALE." [THE MEDICAL EXPERTISE REPORT]. Annales de medecine legale, criminologie, police scientifique et toxicologie vol. 45 (1965): 191-203.
GERVAIS P, DEHOUVE A. E RAPPORT D'EXPERTISE M'EDICALE. [THE MEDICAL EXPERTISE REPORT]. Ann Med Leg Criminol Police Sci Toxicol. 1965 Mar-Apr;45:191-203. French. PMID: 14334555.
Copy Download .nbib Format: NLM
A1 and A2 transitions in superfluid 3He in 98% porosity aerogel.

Physical review letters

Choi HC, Gray AJ, Vicente CL, Xia JS, Gervais G, Halperin WP, Mulders N, Lee Y.
PMID: 15524807
Phys Rev Lett. 2004 Oct 01;93(14):145302. doi: 10.1103/PhysRevLett.93.145302. Epub 2004 Oct 01.

Superfluid 3He in high porosity aerogel is the system in which the effects of static impurities on a p-wave superfluid can be investigated in a systematic manner. We performed shear acoustic impedance measurements on this system (98% porosity aerogel)...

Cite
Choi HC, Gray AJ, Vicente CL, et al. A1 and A2 transitions in superfluid 3He in 98% porosity aerogel. Phys Rev Lett. 2004;93(14):145302doi: 10.1103/PhysRevLett.93.145302.
Choi, H. C., Gray, A. J., Vicente, C. L., Xia, J. S., Gervais, G., Halperin, W. P., Mulders, N., & Lee, Y. (2004). A1 and A2 transitions in superfluid 3He in 98% porosity aerogel. Physical review letters, 93(14), 145302. https://doi.org/10.1103/PhysRevLett.93.145302
Choi, H C, et al. "A1 and A2 transitions in superfluid 3He in 98% porosity aerogel." Physical review letters vol. 93,14 (2004): 145302. doi: https://doi.org/10.1103/PhysRevLett.93.145302
Choi HC, Gray AJ, Vicente CL, Xia JS, Gervais G, Halperin WP, Mulders N, Lee Y. A1 and A2 transitions in superfluid 3He in 98% porosity aerogel. Phys Rev Lett. 2004 Oct 01;93(14):145302. doi: 10.1103/PhysRevLett.93.145302. Epub 2004 Oct 01. PMID: 15524807.
Copy Download .nbib Format: NLM
Competition between a fractional quantum hall liquid and bubble and Wigner crystal phases in the third Landau level.

Physical review letters

Gervais G, Engel LW, Stormer HL, Tsui DC, Baldwin KW, West KW, Pfeiffer LN.
PMID: 15698005
Phys Rev Lett. 2004 Dec 31;93(26):266804. doi: 10.1103/PhysRevLett.93.266804. Epub 2004 Dec 21.

Magnetotransport measurements were performed in an ultrahigh mobility GaAs/AlGaAs quantum well of density approximately 3.0 x 10(11) cm(-2). The temperature dependence of the magnetoresistance Rxx was studied in detail in the vicinity of nu=9/2. In particular, we discovered new...

Cite
Gervais G, Engel LW, Stormer HL, et al. Competition between a fractional quantum hall liquid and bubble and Wigner crystal phases in the third Landau level. Phys Rev Lett. 2004;93(26):266804doi: 10.1103/PhysRevLett.93.266804.
Gervais, G., Engel, L. W., Stormer, H. L., Tsui, D. C., Baldwin, K. W., West, K. W., & Pfeiffer, L. N. (2004). Competition between a fractional quantum hall liquid and bubble and Wigner crystal phases in the third Landau level. Physical review letters, 93(26), 266804. https://doi.org/10.1103/PhysRevLett.93.266804
Gervais, G, et al. "Competition between a fractional quantum hall liquid and bubble and Wigner crystal phases in the third Landau level." Physical review letters vol. 93,26 (2004): 266804. doi: https://doi.org/10.1103/PhysRevLett.93.266804
Gervais G, Engel LW, Stormer HL, Tsui DC, Baldwin KW, West KW, Pfeiffer LN. Competition between a fractional quantum hall liquid and bubble and Wigner crystal phases in the third Landau level. Phys Rev Lett. 2004 Dec 31;93(26):266804. doi: 10.1103/PhysRevLett.93.266804. Epub 2004 Dec 21. PMID: 15698005.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 387 entries